UNIGENE LABORATORIES INC Operating Expenses
UNIGENE LABORATORIES INC reported Operating Expenses of $5.97 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2013-05-14
- UNIGENE LABORATORIES INC operating expenses for the quarter ending 2013-03-31 was $5.97M, a 34.04% increase year-over-year.
- UNIGENE LABORATORIES INC operating expenses for the quarter ending 2012-12-31 was $4.58M, a 25.05% decline year-over-year.
- UNIGENE LABORATORIES INC operating expenses for the quarter ending 2012-09-30 was $5.10M, a 22.36% decline year-over-year.
- UNIGENE LABORATORIES INC operating expenses for the quarter ending 2012-06-30 was $4.67M, a 15.61% decline year-over-year.
- UNIGENE LABORATORIES INC operating expenses for fiscal 2012 was $18.81M, a 21.55% decline from fiscal 2011.
- UNIGENE LABORATORIES INC operating expenses for fiscal 2011 was $23.97M, a 10.66% increase from fiscal 2010.
- UNIGENE LABORATORIES INC operating expenses for fiscal 2010 was $21.66M, a 13.93% decline from fiscal 2009.
- UNIGENE LABORATORIES INC operating expenses for fiscal 2009 was $25.17M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2013-03-31 | $5.97M 10-Q · filed 2013-05-14 | $10.55M derived: sum of 2 quarters · filed 2013-05-14 | $15.65M derived: sum of 3 quarters · filed 2013-05-14 | $20.33M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-12-31 | $4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $9.68M derived: sum of 2 quarters · filed 2013-03-15 | $14.35M derived: sum of 3 quarters · filed 2013-03-15 | $18.81M 10-K · filed 2013-03-15 |
| 2012-09-30 | $5.10M 10-Q · filed 2013-01-31 | $9.77M derived: sum of 2 quarters · filed 2013-01-31 | $14.23M 10-Q · filed 2013-01-31 | $20.34M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-06-30 | $4.67M 10-Q/A · filed 2013-01-31 | $9.13M 10-Q/A · filed 2013-01-31 | $15.24M derived: sum of 3 quarters · filed 2013-05-14 | $21.81M derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-03-31 | $4.46M 10-Q · filed 2013-05-14 | $10.56M derived: sum of 2 quarters · filed 2013-05-14 | $17.13M derived: sum of 3 quarters · filed 2013-05-14 | $22.67M derived: sum of 4 quarters · filed 2013-05-14 |
| 2011-12-31 | $6.11M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $12.68M derived: sum of 2 quarters · filed 2013-03-15 | $18.21M derived: sum of 3 quarters · filed 2013-03-15 | $23.97M 10-K · filed 2013-03-15 |
| 2011-09-30 | $6.57M 10-Q · filed 2013-01-31 | $12.11M derived: sum of 2 quarters · filed 2013-01-31 | $17.87M 10-Q · filed 2013-01-31 | $23.48M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | $5.54M 10-Q/A · filed 2013-01-31 | $11.30M 10-Q/A · filed 2013-01-31 | $16.91M derived: sum of 3 quarters · filed 2013-03-15 | $21.60M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | $5.76M 10-Q/A · filed 2013-01-31 | $11.37M derived: sum of 2 quarters · filed 2013-03-15 | $16.06M derived: sum of 3 quarters · filed 2013-03-15 | $22.09M derived: sum of 4 quarters · filed 2013-03-15 |
| 2010-12-31 | $5.61M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $10.30M derived: sum of 2 quarters · filed 2013-03-15 | $16.33M derived: sum of 3 quarters · filed 2013-03-15 | $21.66M 10-K · filed 2013-03-15 |
| 2010-09-30 | $4.69M 10-Q · filed 2011-11-09 | $10.72M derived: sum of 2 quarters · filed 2011-11-09 | $16.05M 10-Q · filed 2011-11-09 | |
| 2010-06-30 | $6.03M 10-Q · filed 2011-08-09 | $11.36M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $25.17M 10-K/A · filed 2013-01-31 |